ApprovalTrail

Approval · Notice of Compliance 19050 · 2017

BRINAVESS: Notice of Compliance 19050

Issued March 13, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
19050
Date
March 13, 2017
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
New Active Substance (NAS)

Products in this notice

BrandDINStatus today
BRINAVESS02462400Marketed

Medicinal ingredients